The present invention relates to compounds that are useful for treating cellular proliferative diseases, for treating disorders mediated, at least in part, by KSP, and for inhibiting KSP. The invention also related to pharmaceutical compositions comprising such compounds, methods of treating cancer by the administration of such compositions, and processes for the preparation of the compounds. Compounds of the invention have the following formula: ##STR00001##

 
Web www.patentalert.com

< Protection of cardiac myocardium

> PGD2 receptor antagonists for the treatment of inflammatory diseases

> Antagonists of the vanilloid receptor subtype 1 (VR1) and use thereof

~ 00504